Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis
We present the first case of a male patient with an epidermal growth factor receptor (EGFR) 19del mutation who was diagnosed with intra-abdominal aggressive fibromatosis and familial adenomatous polyposis. We assessed the clinical response of the patient to first-generation EGFR-tyrosine kinase inhi...
Saved in:
| Main Authors: | Yanjing Guo, Jingjing Wu, Qianming Bai, Juefeng Wan, Qifeng Wang, Xinhong He, Xiaowei Zhang, Zhiguo Luo, Liju Xing, Xin Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1537714/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number
by: Xinyi Lv, et al.
Published: (2025-07-01) -
Aggressive intraabdominal fibromatosis
by: Stojković Mirjana, et al.
Published: (2006-01-01) -
Fibromatosis with aggressive demeanor: Benign impersonator of malignancy
by: Naveen Kumar, et al.
Published: (2021-03-01) -
Fibromatosis dérmica
by: Gerzain Rodríguez T., et al.
Published: (2001-10-01) -
GEFITINIB (IRESSA) IN THE TREATMENT OF BRAIN METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)